Keyphrases
5-azacytidine
18%
Basal Cell Hyperplasia
18%
Carcinoma Cell Lines
18%
China
9%
Correlation Analysis
9%
CpG Island
9%
CpG Island Methylation
18%
DNA Hypermethylation
9%
DNA Methyltransferase Inhibitor
9%
Dysplasia
18%
Early Lesions
9%
Esophageal Squamous Carcinoma Cell
18%
Esophageal Squamous Cell Carcinoma
9%
Gene Silencing
9%
Human Esophageal Squamous Cell Carcinoma
100%
Hypermethylation
100%
In Situ Hybridization
9%
Inhibitor-2
9%
MRNA Expression
27%
MRNA Level
9%
Normal Epithelium
9%
Oncogenesis
27%
Promoter Region
27%
Quantitative Methylation-specific PCR (Q-MSP)
9%
Receptor Expression
18%
Receptor Gene
18%
Retinoic Acid Receptor
100%
Same Patient
9%
Statistical Correlation
9%
Medicine and Dentistry
Azacitidine
18%
Basal Cell
9%
Carcinogenesis
27%
Cell Hyperplasia
18%
CpG Island
27%
DNA Methylation
9%
DNA Methyltransferase Inhibitor
9%
Dysplasia
18%
Epithelium Basal Cell
9%
Esophageal Squamous Cell Carcinoma
100%
Esophageal Squamous Cell Carcinoma Cell Line
18%
Gene Inactivation
9%
In Situ Hybridization
9%
Messenger RNA
36%
Methylation
9%
Promoter Region
36%
Receptor Expression
18%
Receptor Gene
18%
Retinoic Acid Receptor
100%
Pharmacology, Toxicology and Pharmaceutical Science
Azacitidine
18%
Carcinogenesis
27%
Cell Hyperplasia
18%
DNA Methyltransferase Inhibitor
9%
Dysplasia
18%
Esophageal Squamous Cell Carcinoma
100%
Messenger RNA
36%
Retinoic Acid Receptor
100%